Galderma to buy US firm ZO Skin Health for $1.5 billion

FILE PHOTO: A logo of skin care company Galderma is pictured on the company's offices in Lausanne, Switzerland, March 13, 2024.

FILE PHOTO: A logo of skin care company Galderma is pictured on the company's offices in Lausanne, Switzerland, March 13, 2024. (REUTERS/Denis Balibouse/File Photo)


1 photo
Save Story

Estimated read time: Less than a minute

ZURICH, Oct 14 — Swiss skincare firm Galderma ​said on Wednesday it had agreed to acquire US-based company ‌ZO Skin Health for an enterprise value ⁠of $1.5 billion.

• ​The acquisition brings ⁠together two complementary, science-backed skincare ‌brands, ZO ‌Skin Health and Galderma's Alastin

• Galderma ⁠said the ⁠deal would expand its dermatological skincare offering in fast-growing, physician-dispensed skincare and support ZO Skin Health's next phase of growth.

• The ‌transaction is expected ​to close in the fourth quarter of 2026 or early 2027, subject to regulatory approvals.

• The Swiss company said the acquisition of 100% of ZO Skin ​Health is expected to be ‌neutral to ‌core ⁠earnings per share in the first full year after the transaction closes.

• Irvine, California-based ZO Skin ‌Health has operated ​in professional skincare ‌for more than ⁠20 ​years.

(Writing by Dave GrahamEditing by Linda ​Pasquini)

Photos

Most recent Lifestyle stories

Related topics

STAY IN THE KNOW

Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Notice.
Newsletter Signup

KSL Weather Forecast

KSL Weather Forecast
Play button